Preview

Медицинский Совет

Расширенный поиск

Функциональные расстройства в неврологической практике

https://doi.org/10.21518/2079-701X-2015-5-62-69

Полный текст:

Аннотация

В статье обсуждаются основные клинические проявления, подходы к диагностике и современные методы терапии функциональных расстройств.

Об авторе

Г. М. Дюкова
Первый Московский государственный медицинский университет им. И.М. Сеченова
Россия


Список литературы

1. BarskyAJ, Orav EJ, Bates DW: Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Archives of General Psychiatry, 2005, 62: 903-910. Delius L. Fahrenberg J. Psychovegetative Syndrome Thieme, 1966: 290. Dharmshaktu P, Tayal V, Kalra BS. Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol, 2012, 52(1): 6-17. Epub 2011 Mar 17. Dyukova GM, Shepeleva IP, Vorob'eva OV. Treatment of vegetative crises (panic attacks). Neurosci Behav Physiol, 1992, 22(4): 343-5. Fishbain D. Evidence-based data on pain relief with antidepressants. Ann Med, 2000, 32(5): 305-16. Floris P de Lange, Joke S Kalkman, Gijs Bleijenberg, Peter Hagoort, Sieberen P vd Werf, Jos WM van der Meer and Ivan Toni Neural correlates of the chronic fatigue syndrome-an fMRI study. Brain, 2004, 127(9): 1948-1957. Freire RC, Hallak JE, Crippa JA, Nardi AE.New treatment options for panic disorder: clinical trials from 2000 to 2010. Expert Opin Pharmacother, 2011, 12(9): 1419-28. Gorman JM. The use of newer antidepressants for panic disorder. J Clin Psychiatry, 1997, 58 Suppl 14:54-8; discussion 59. Kircanski K. Craske MG, Epstein A. Wittchen H-U. Subtypes of Panic Attacks: A critical rev of the empirical literature. Depression and Anxiety, 2009, 26: 878-887. Lempert T, Dieterich M, Huppert D, Brandt T. Psychogenic disorders in neurology. Frequency and clinical spectrum. Acta Neurol Scand, 1990, 82: 335-340.

2. Leombruni P, Piero A, Lavagnino L, Brustolin A, Campisi S, Fassino S. A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with binge eating disorder. Prog Neuropsychophar-macol Biol Psychiatry, 2008, 32(6): 1599-1605.

3. Mazza M, Mazza O, Pazzaglia C, Padua L, Mazza S. Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain. Expert Opin Pharmacother, 2010, 11(7): 1049-52.

4. Muller jE, Wentzel I, Koen L, Niehausb DJH. Seedat S and Stein DJ. Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial. Int ClinPsychopharmacol, 2008, 23: 43-48.

5. Owens MJ, Knight DL, Nemeroff CB. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol.Ps., 2001, 50: 345-50.

6. Pae CU, Marks DM, Patkar AA, Masand PS, Luyten P, Serretti A.Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants. Expert Opin Pharmacother, 2009, 10(10): 1561-70.

7. Perkin GD. An analysis of 7836 successive new outpatient referrals. J Neurol Neurosurg Psychiatr, 1989, 52: 447-448.

8. Pollack MH, Allgulander C, Bandelow B, Cassano GB, Greist JH, Hollander E, Nutt DJ, Okasha A, Swinson RP; World Council of Anxiety. WCA recommendations for the long-term treatment of panic disorder. CNS Spectr, 2003, 8(8): 17-30.

9. Sharpe M, Mayou R, Bass C. Concepts, theories and terminology. In: Mayou R, Bass C, Sharpe M, eds. Treatment of functional somatic symptoms. Oxford: Oxford University Press, 1995: 3-16.

10. Stone J, Carson A, Duncan R, Coleman R, Roberts R, Warlow C, Hibberd C, Murray G, Cull R, Pelosi A, Cavanagh J, Matthews K, Goldbeck R, Smyth R, Walker J, MacMahon AD. Sharpe M. Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain, 2009, 132: 2878-2888.

11. Stone J et al. «Who is referred to neurology clin-ics?-the diagnoses made in 3781 new patients». Clin Neurol Neurosurg, 2010, 112(9): 747-51.

12. Stone J, Carson A, Sharpe M. Functional symptoms and signs in neurology: assessment and diagnosis. J Neurol Neurosurg Psychiatry, 2005, 76: 2-12.

13. Ursin H, Eriksen HR. Sensitization, subjective health complaints, and sustained arousal. Ann N YAcad Sci, 2001, 933: 119-29.

14. Vein A.M, Dyukova GM, Vorobieva OV. Is panic attack a mask of psychogenic seizures? A comparative analysis of phenomenology of psycho-genic seizures and panic attacks. «Functional neurology», 1994, IX(3): 153-161.

15. Waugh J, Goa KL. Escitalopram: a review of its use in the management of major depressive and anxiety disorders. CNS Drugs, 2003, 17(5): 343-62.

16. Дюкова П М. Основные принципы диагностики истерии в неврологии. Избранные лекции. Эйдос-Медиа, 2006: 316-337.

17. Куликовский В. В. Клинико-патогенетические аспекты астенического синдрома психогенного и соматогенного генеза: дис.. д-ра мед. наук. М., 1994. С. 482.

18. Родштат И.В. Вопросы клиники и патогенеза астенических состояний (неврологический и психологический анализ): дис. д-ра мед. наук. М., 1967. С. 265.


Просмотров: 127


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)